After a noteworthy conditional loan commitment, Gevo, Inc. (NASDAQ: GEVO) shares are seeing notable gains on the US stock charts. The value of GEVO shares
On February 24, 2022, Gevo Inc. (GEVO) posted its Q4 2021 financial results along with operational highlights and updates. As a result, the company’s stock
For Martin Luther King Day, the U.S. treasuries were closed yesterday. In the meantime, on Wednesday, the Americans are waiting for the unveiling of Joe
Bionano Genomics Inc. (BNGO) stock soared 55.84% to $4.8 in the pre-market trading. The company recently granted 180-day extension by Nasdaq to regain compliance with
Bionano Genomics Inc. (BNGO) stock soared 46.62% to $1.95 in the pre-market trading after reporting that Praxis Genomics, LLC received accreditation from the College of
Greenpro Capital Corp. (GRNQ), a Conglomerates company, dropped about -5.88% at $1.76 in pre-market trading Tuesday after announcing Bitcoin fund. ATIF Holdings Limited (ATIF) stock
Avinger Inc. (AVGR) stock plunged -7.38% to $0.4445 in the pre-market trading. The most recent rating by Ladenburg Thalmann, on March 09, 2018, is a
Ocugen Inc. (OCGN) stock plunged -8.85% to $2.37 in the pre-market trading after reporting the appointment of a vaccine scientific advisory board comprised of leading
Velodyne Lidar Inc. (VLDR) stock soared 7.5% to $26.53 in the pre-market trading after reporting that it has joined the Qualcomm® Smart Cities Accelerator Program
Seneca Biopharma Inc. (SNCA), a Biotechnology company, rose about 0.2% at $0.96 in pre-market trading Friday after declaring merger agreement with Leading BioSciences, Inc. under
At Stocktstelegraph.com, we are committed to helping investors make smart and profitable decisions. Our goal is to make investing easier and more accessible to everyone. We strive to provide the best and most reliable market information, news and analysis to ensure that our readers can make informed decisions.